Pfenex is to be acquired by Ligand Pharmaceuticals in a deal that is valued at up to $516m, the companies have announced.
Ligand has signed a definitive agreement to acquire all outstanding shares of Pfenex for $12.00 per share in cash, or...
Ligand Pharmaceuticals has struck a deal to acquire Pfenex in a transaction valued at up to $516m.

Pfenex is to be acquired by Ligand Pharmaceuticals in a deal that is valued at up to $516m, the companies have announced.
Ligand has signed a definitive agreement to acquire all outstanding shares of Pfenex for $12.00 per share in cash, or...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.